CME Enduring Materials

Funding provided through educational grants from pharmaceutical industry supporters.

Advances in the Diagnosis, Pathogenesis, and Management of Fibromyalgia Syndrome Release Date: March 2008 Termination Date: 3/31/2010 Supported by: Eli Lilly and Company and Pfizer Inc

Creativity and Dementia: Emerging Diagnostic and Treatment Methods for Alzheimer’s Disease Release Date: February 2008 Termination Date: 2/28/2010 Supported by: Myriad Pharmaceuticals, Inc.

Augmentation Strategies in the Treatment of Major Depressive Disorder Release Date: December 2007 Termination Date: 12/31/2009 Supported by: Bristol-Myers Squibb

Other CME Enduring Materials Available By Disease State

Addictive Disorders	Miscellaneous
Alcohol-Related Disorders	Mood Disorders
Anxiety Disorders	Movement Disorders
Attention-Deficit/Hyperactivity Disorder	Multiple Sclerosis
Autism Spectrum Disorders	Neurodegenerative Disorders
Bipolar Disorders	Neuropathy
Body Dysmorphic Disorder	Parkinson’s Disease
Brain Imaging	Personality Disorders
Chronic Pain	Pharmacologic Treatments
Dementia	Postpartum Depression
Depression	Psychosis
Eating Disorders	Schizophrenic Disorders
Epilepsy	Sexual Dysfunction
Fibromyalgia	Sleep Disorders
Impulse-Control Disorders	Stroke
Irritable Bowel Syndrome	Treatment Adherence
Malingering